ACADIA Pharmaceuticals, Inc. Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2009

SAN DIEGO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today reported its financial results for the fourth quarter and year ended December 31, 2009.

MORE ON THIS TOPIC